Quick Answer
APOE genotype is a genetic test that estimates inherited susceptibility to late-onset Alzheimer’s disease. It identifies which versions, or alleles, of the APOE gene you inherited from your parents.
In the uploaded report, the result was APOE E3/E3. This means no APOE E4 allele was detected. E3/E3 is the most common APOE genotype and is not associated with the increased Alzheimer’s disease risk seen in APOE E4 carriers. The report specifically states that this E3/E3 result is negative for APOE E4 and is not associated with increased risk for late-onset Alzheimer’s disease in that context.
APOE testing does not diagnose Alzheimer’s disease and does not predict with certainty whether someone will or will not develop Alzheimer’s disease. Genetic counseling is recommended when interpreting this result.
4 things to know about APOE genotype
-
APOE testing estimates genetic risk, but it does not diagnose Alzheimer’s disease.
-
Everyone inherits one APOE allele from each parent. The most common alleles are E2, E3, and E4.
-
The APOE E4 allele increases susceptibility, but it does not determine whether Alzheimer’s disease will occur.
-
Lifestyle and cardiovascular health still matter, regardless of genotype. Age, family history, blood pressure, diabetes, sleep, exercise, metabolic health, and other genes all influence overall risk.
What is APOE genotype?
APOE stands for apolipoprotein E, a protein involved in lipid transport and metabolism. The APOE gene has several common forms, usually called E2, E3, and E4.
Your APOE genotype is the combination of two alleles you inherited — one from each parent. For example:
| Genotype | What it means |
|---|---|
| E3/E3 | Two E3 alleles |
| E3/E4 | One E3 allele and one E4 allele |
| E4/E4 | Two E4 alleles |
| E2/E3 | One E2 allele and one E3 allele |
The APOE gene is considered a susceptibility gene for late-onset Alzheimer’s disease. This means it can influence risk, but it does not cause Alzheimer’s disease by itself. The uploaded report notes that APOE E4 increases lifetime risk but is neither necessary nor sufficient for the development of Alzheimer’s disease.
What does APOE genotype mean for Alzheimer’s risk?
The main allele doctors look for is APOE E4.
Carrying an APOE E4 allele increases susceptibility to late-onset Alzheimer’s disease, but it is only one of many contributing factors. Age, family history, cardiovascular health, diabetes, blood pressure, physical activity, sleep, education, head trauma history, and other genetic factors all influence overall risk.
Many APOE E4 carriers never develop Alzheimer’s disease. Many people without APOE E4 still can develop Alzheimer’s disease.
That is why APOE genotype should be interpreted as a risk marker, not a diagnosis or prediction.
APOE genotype result table
| Genotype | Typical interpretation |
|---|---|
| E2/E2 | May be associated with lower Alzheimer’s disease risk compared with E3, although risk is not eliminated |
| E2/E3 | No APOE E4 detected; generally not associated with increased APOE E4-related risk |
| E3/E3 | Most common genotype; no APOE E4 detected |
| E3/E4 | One APOE E4 allele; associated with increased susceptibility |
| E4/E4 | Two APOE E4 alleles; associated with the greatest APOE-related susceptibility |
Rare or indeterminate results: Some reports may mention E1/E4 or an indeterminate E2/E4 vs E1/E3 result. The uploaded report notes that this assay cannot distinguish E2/E4 from E1/E3 and that the E1 allele is rare. These results should be interpreted carefully with the lab report and, ideally, a genetic counselor.
What does APOE E3/E3 mean?
APOE E3/E3 means you inherited two E3 alleles and no APOE E4 allele was detected.
This is the most common APOE genotype. It is generally considered the typical or neutral genotype for APOE-related Alzheimer’s disease risk. In the uploaded report, the patient’s E3/E3 result is described as negative for APOE E4 and not associated with increased risk for late-onset Alzheimer’s disease in that context.
An E3/E3 result is reassuring, but it does not mean Alzheimer’s disease is impossible. Alzheimer’s risk is influenced by many other factors besides APOE.
Can I get Alzheimer’s disease if I have E3/E3?
Yes.
An E3/E3 result means you do not have the increased APOE E4-related risk. It does not mean your lifetime risk is zero.
People with E3/E3 can still develop Alzheimer’s disease, especially as they age or if they have other risk factors such as family history, vascular disease, diabetes, high blood pressure, poor sleep, or other genetic contributors.
What does APOE E3/E4 mean?
APOE E3/E4 means you inherited one E3 allele and one E4 allele.
This result is associated with increased susceptibility to late-onset Alzheimer’s disease compared with E3/E3. However, it is not diagnostic. Many people with E3/E4 never develop Alzheimer’s disease.
A helpful way to understand E3/E4 is:
It raises risk, but it does not determine outcome.
Lifestyle, cardiovascular health, metabolic health, sleep, exercise, and overall medical history still matter.
What does APOE E4/E4 mean?
APOE E4/E4 means you inherited two APOE E4 alleles.
This genotype is associated with the greatest APOE-related susceptibility to late-onset Alzheimer’s disease. However, even E4/E4 is not a diagnosis. It does not mean Alzheimer’s disease is certain.
Someone with E4/E4 should consider discussing the result with a clinician or genetic counselor, especially if they have memory symptoms, a strong family history of dementia, or are considering Alzheimer’s-related screening or prevention strategies.
Can I stay healthy if I have APOE E4/E4?
Yes.
APOE E4/E4 increases genetic susceptibility, but it does not guarantee disease. Some people with E4/E4 never develop Alzheimer’s disease.
This is one reason the result should be used as context, not destiny. Brain health is influenced by many factors, including blood pressure, insulin resistance, cholesterol and vascular health, exercise, sleep quality, hearing, social connection, cognitive activity, smoking status, alcohol use, and overall inflammation.
What does APOE E2/E2 or E2/E3 mean?
APOE E2/E2 and APOE E2/E3 mean no APOE E4 allele was detected.
Compared with APOE E3, the E2 allele has generally been associated with a lower risk of late-onset Alzheimer’s disease in population studies, although it does not prevent the disease. The uploaded report also notes that APOE E2 may have some protective effect against development of late-onset disease.
APOE E2 can also be relevant to lipid metabolism, so the result should be interpreted in the broader context of cholesterol, triglycerides, cardiovascular risk, and clinical history.
Can your APOE genotype change?
No.
Unlike cholesterol, glucose, liver enzymes, or inflammation markers, your APOE genotype does not change over time.
You inherit your APOE genotype at conception, and it remains the same throughout life. If the test is repeated, the result should usually be the same, unless there was a sample, reporting, or technical issue.
Who should consider APOE testing?
APOE testing may be considered in selected situations, such as:
| Situation | Why it may be considered |
|---|---|
| Family history of Alzheimer’s disease | May help clarify inherited susceptibility, especially when interpreted with counseling |
| Memory clinic evaluation | May be used as part of a broader cognitive or neurologic assessment |
| Alzheimer’s research studies | Often used to stratify risk or study disease biology |
| Certain treatment decisions | APOE status may be relevant in some specialized Alzheimer’s disease treatment discussions |
| Personal risk assessment | Some people want to understand genetic susceptibility, but counseling is important |
APOE testing is generally not recommended as a stand-alone population screening test because it cannot predict or rule out Alzheimer’s disease. The uploaded report explicitly states that this test cannot predict or rule out Alzheimer’s disease and recommends genetic counseling.
Why is APOE genotype tested?
APOE genotype may be ordered to help assess inherited susceptibility to late-onset Alzheimer’s disease.
It may also provide context for lipid metabolism because APOE is involved in how the body transports and processes fats. However, when ordered as an Alzheimer’s risk test, the main clinical question is usually whether the person carries zero, one, or two APOE E4 alleles.
Methodology and assay notes
The uploaded Labcorp report states that the test uses custom genotyping arrays to evaluate two common APOE variants:
| Variant | Identifier |
|---|---|
| APOE c.388T>C | rs429358 |
| APOE c.526C>T | rs7412 |
These two variants are used to determine the common APOE E2, E3, and E4 allele combinations. The report states that analytical sensitivity and specificity are greater than 99%.
The report also notes important limitations, including that rare errors can occur and that some rare genotype combinations may not be distinguishable by this assay.
Important limitations
APOE genotype has several important limitations:
| Limitation | What it means |
|---|---|
| Not diagnostic | APOE genotype cannot diagnose Alzheimer’s disease |
| Not predictive with certainty | It cannot tell whether someone will or will not develop Alzheimer’s disease |
| E4 is not required | Alzheimer’s disease can occur without APOE E4 |
| E4 is not sufficient | Many people with APOE E4 never develop Alzheimer’s disease |
| Clinical context matters | Age, symptoms, family history, vascular health, and other factors matter |
| Counseling is recommended | Especially for E4-positive, rare, indeterminate, or emotionally distressing results |
The report specifically states that APOE testing cannot predict or rule out Alzheimer’s disease and recommends genetic counseling.
Related biomarkers and health factors
APOE genotype is best interpreted alongside clinical history and other markers of cognitive, metabolic, vascular, and inflammatory health.
| Related marker or factor | Why it may matter |
|---|---|
| Amyloid beta 42/40 ratio | Alzheimer’s-related amyloid pathology marker |
| Phosphorylated tau | Alzheimer’s-related tau pathology marker |
| Total tau | Marker of neuronal injury |
| Neurofilament light chain | General marker of neurodegeneration or nerve injury |
| HbA1c | Long-term glucose and metabolic risk context |
| Fasting glucose / fasting insulin | Insulin resistance and metabolic health context |
| Blood pressure | Vascular and cognitive health risk factor |
| LDL-C / ApoB / Lp(a) | Cardiovascular and cerebrovascular risk context |
| hs-CRP | Inflammation and vascular risk context |
| Homocysteine | Vascular and cognitive risk context |
| Vitamin B12 / Folate | Reversible contributors to cognitive symptoms |
Your APOE genotype shows which versions of the APOE gene you inherited. APOE is involved in fat and cholesterol transport and is also linked to inherited susceptibility to late-onset Alzheimer’s disease.
The most important allele for Alzheimer’s risk interpretation is APOE E4.
If your result is E3/E3, no APOE E4 allele was detected. This is the most common genotype and is not associated with the increased APOE E4-related risk.
If your result includes one E4 allele, such as E3/E4, your inherited susceptibility is higher than someone with E3/E3.
If your result is E4/E4, your APOE-related susceptibility is higher still.
However, APOE genotype is not destiny. It does not diagnose Alzheimer’s disease, and it cannot predict your future with certainty. Your overall risk depends on many other factors, including age, family history, cardiovascular health, metabolic health, sleep, exercise, and other genes.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →Frequently Asked Questions
Is APOE genotype a test for Alzheimer’s disease?
Is E3/E3 normal?
Can I get Alzheimer’s disease if I have E3/E3?
Does E3/E4 mean I will get Alzheimer’s disease?
Does E4/E4 mean Alzheimer’s disease is certain?
Can I stay healthy if I have E4/E4?
Can APOE genotype change over time?
Can APOE testing rule out Alzheimer’s disease?
Should I get genetic counseling for an APOE result?
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.